GHK-Cu and microneedling for pores and acne scars: what the data says
Quick answer
The creator is attempting to treat atrophic acne scarring, specifically boxcar subtype, using a topical peptide serum marketed as having a microneedling-like effect. Boxcar scars result from collagen loss in the dermis and are not meaningfully addressed by topical-only interventions in current clinical literature. The tingling sensation she describes on application likely indicates a low-pH or active ingredient in the formula rather than any mechanical skin-remodeling action.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @xxpushinpretty actually say?
The creator says she's been using the Reedleshot 300 serum, which she describes as having a "micro needleling effect," to try to reduce what she calls "teeny holes" or boxcar acne scars. She reports a tingling sensation on application and believes she's seeing progress. She's pairing it with a pore-minimizing gel cream and treating the combo as a gentler first step before committing to actual microneedling procedures.
Her approach is genuinely reasonable in framing: try topicals before escalating to in-office treatments. She's not claiming a cure. She's saying "I low key high key think they do" get better, which is about as measured as TikTok skincare gets. She correctly identifies the scars as boxcar type, even if she initially fumbles the name, and she's honest that the 300 concentration felt stronger and faster-acting than the 100.
Does the science back this up?
This depends entirely on what's actually in Reedleshot 300, and that's where things get murky. The product name suggests a peptide or bioactive concentration formula. If it contains GHK-Cu (copper tripeptide-1), there is legitimate peer-reviewed support for its role in skin remodeling.
Pickart and Margolina (2018, Cosmetics) documented GHK-Cu's ability to stimulate collagen and glycosaminoglycan synthesis, which is relevant to scar remodeling. However, that research is largely in vitro or animal-based. Human clinical trials on GHK-Cu specifically for atrophic acne scars, the kind causing boxcar depressions, are limited. A 2015 study by Leyden et al. in the Journal of Cosmetic Dermatology found peptide-containing creams improved skin texture, but effect sizes were modest and follow-up periods short. The tingling she feels could reflect a mild acid or retinoid component rather than anything peptide-specific. Tingling alone is not evidence of remodeling.
What did they get wrong (or right)?
She got the scar classification mostly right. Boxcar scars are defined by vertical edges and flat bases, distinct from ice pick scars (narrow, deep) and rolling scars (sloped edges). She conflates them briefly but lands on boxcar, which matches what she's showing.
Where she oversimplifies: describing a topical as having a "micro needleling effect" is a marketing phrase, not a mechanism. Microneedling works by creating controlled dermal injury that triggers the wound-healing cascade, including TGF-beta signaling and new collagen deposition at depth. A topical, regardless of its peptide content, cannot replicate dermal injury. It can support surface-level hydration and potentially stimulate fibroblast activity, but it is not the same process. Calling it equivalent is misleading, even if she got that language from the product marketing rather than inventing it herself.
She also doesn't mention SPF once. Atrophic scar treatment of any kind is undermined significantly by UV exposure, which degrades new collagen. That's a real omission.
What should you actually know?
Boxcar acne scars are among the hardest cosmetic concerns to treat topically. They involve structural loss of dermal collagen, and no topical product has been shown in rigorous clinical trials to fully restore that volume. That's not pessimism, it's the current evidence base.
Peptides like GHK-Cu do have legitimate mechanisms relevant to skin repair. But "relevant mechanism" is not the same as "proven clinical outcome for atrophic scarring." The gap between in vitro collagen stimulation and visible scar reduction in humans is wide. If you're considering this product category, keep expectations calibrated. Topicals may improve skin texture and surface appearance, and that's worth something. But for true boxcar scars, procedures like microneedling with radiofrequency, subscision, or fractional laser have the strongest evidence base, per a 2019 systematic review by Fabbrocini et al. in the Journal of the European Academy of Dermatology and Venereology. Seeing a board-certified dermatologist before spending money on a product stack is not extreme, it's the smarter first step.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
GHK-Cu (Copper Peptide) access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 4 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GHK-Cu and microneedling for pores and acne scars: what the data says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
GHK-Cu (Copper Peptide) is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this ghk-cu video claims cluster
Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.
Claim verdict
The useful answer behind this video
Claim being checked
The creator is attempting to treat atrophic acne scarring, specifically boxcar subtype, using a topical peptide serum marketed as having a microneedling-like effect.
FormBlends verdict
The creator is attempting to treat atrophic acne scarring, specifically boxcar subtype, using a topical peptide serum marketed as having a microneedling-like effect. Boxcar scars result from collagen loss in the dermis and are not meaningfully addressed by topical-only interventions in current clinical literature. The tingling sensation she describes on application likely indicates a low-pH or active ingredient in the formula rather than any mechanical skin-remodeling action.
Patient-safe next step
Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is attempting to treat atrophic acne scarring, specifically boxcar subtype, using a topical peptide serum marketed as having a microneedling-like effect. Boxcar scars result from collagen loss in the dermis and are not meaningfully addressed by topical-only interventions in current clinical literature. The tingling sensation she describes on application likely indicates a low-pH or active ingredient in the formula rather than any mechanical skin-remodeling action.
- Boxcar acne scars involve structural collagen loss in the dermis; the American Academy of Dermatology notes no topical alone has demonstrated reliable volume restoration in this scar type.
- GHK-Cu (copper tripeptide-1) has in vitro evidence for collagen stimulation (Pickart and Margolina, 2018, Cosmetics), but human clinical trials specifically for atrophic acne scarring remain limited.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.
Review GHK-Cu (Copper Peptide)What You'll Learn
- Boxcar acne scars involve structural collagen loss in the dermis; the American Academy of Dermatology notes no topical alone has demonstrated reliable volume restoration in this scar type.
- GHK-Cu (copper tripeptide-1) has in vitro evidence for collagen stimulation (Pickart and Margolina, 2018, Cosmetics), but human clinical trials specifically for atrophic acne scarring remain limited.
- A 2019 systematic review by Fabbrocini et al. in the Journal of the European Academy of Dermatology and Venereology identified microneedling, subscision, and fractional laser as the procedures with strongest evidence for boxcar scar improvement.
- Tingling on application signals an active ingredient is present, not that dermal remodeling is occurring; these are different biological events at different skin depths.
- No SPF mention in this routine is a real gap: UV exposure degrades newly synthesized collagen, which is especially counterproductive during any scar-improvement protocol.
- The phrase 'microneedling effect' in topical product marketing has no standardized clinical definition and should be treated as a consumer-facing claim, not a mechanism statement.
- Self-reported visual improvement in a non-controlled setting can reflect hydration, reduced inflammation, or lighting differences as much as actual scar remodeling.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
M A R L Y N N A E · TikTok creator
202.6K views on this video
I think it’s getting betttter no cizzyyy #largepores #boxscars #acne #reedleshot300 #poreminimizing
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by M A R L Y N N A E, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.